Table 2 Dissection of the anomalous exponent β and generalised diffusion coefficient Kβ for each of the three diffusion regimes (subdiffusive, Brownian and superdiffusive) and their percentage

From: Concurrent diffusion of nicotinic acetylcholine receptors and fluorescent cholesterol disclosed by two-colour sub-millisecond MINFLUX-based single-molecule tracking

Anomalous exponent β and generalised diffusion coefficient Kβ

Experimental condition

Subdiffusive

Brownian

Superdiffusive

%

Kβ

β

%

Kβ

β

%

Kβ

β

CF®640-BTX

19.44 ± 2.14

0.062 ± 0.002

0.78 ± 0.01

33.47 ± 2.50

0.149 ± 0.005

1.00 ± 0.01

47.09 ± 3.37

0.530 ± 0.02

1.28 ± 0.01

CF®640-BTX upon cholesterol depletion (CDx)

28.28 ± 2.56

0.051 ± 0.002

0.77 ± 0.01

31.34 ± 2.83

0.118 ± 0.006

0.97 ± 0.01

40.39 ± 4.91

0.379 ± 0.031

1.31 ± 0.01

CF®680-BTX

15.01 ± 2.14

0.062 ± 0.006

0.80 ± 0.01

29.06 ± 3.58

0.130 ± 0.010

1.01 ± 0.01

55.92 ± 5.00

0.662 ± 0.074

1.34 ± 0.02

fPEG-Chol

5.34 ± 0.89

0.124 ± 0.007

0.77 ± 0.01

15.65 ± 1.12

0.292 ± 0.011

1.02 ± 0.01

79.01 ± 1.62

1.689 ± 0.057

1.33 ± 0.01

CF®680-BTX (+fPEG-Chol)

13.01 ± 2.01

0.095 ± 0.006

0.74 ± 0.01

27.50 ± 2.31

0.345 ± 0.014

1.01 ± 0.01

59.50 ± 3.12

1.475 ± 0.069

1.29 ± 0.01

fPEG-Chol (+CF®680-BTX)

10.96 ± 0.86

0.353 ± 0.005

0.77 ± 0.01

30.30 ± 1.66

0.868 ± 0.009

1.01 ± 0.01

58.74 ± 2.25

2.482 ± 0.033

1.26 ± 0.01